Diagnostics expansion Ellume is expanding from at-home diagnostics to tuberculosis testing through partnerships with Qiagen, signaling a potential sales opportunity for diagnostic assay development, connected care platforms, and manufacturing support in TB testing solutions.

Clinical connectivity With a focus on connected real-time diagnostics and care technologies, there is a potential to offer cloud-enabled data integration, analytics, and device-to-cloud solutions to healthcare providers seeking seamless results reporting and remote monitoring.

Manufacturing scale Ellume has ambitions to grow headcount and manufacturing capacity, presenting opportunities for scalable manufacturing services, quality systems, supply chain optimization, and extended production partnerships.

Regulatory track Past recalls and FDA engagements indicate a need for robust compliance, quality assurance, and post-market surveillance solutions that could be bundled with manufacturing and software to ensure ongoing regulatory readiness.

Strategic collaborations Active international partnerships with Qiagen and potential expansion into global markets create openings for channel partnerships, joint go-to-market strategies, and integrated solutions across regions.